Yale Bulletin and Calendar

October 29, 2004|Volume 33, Number 9



BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Malfunction of the mitochondria (blue) may underlie problems of aging such as hypertension and high blood cholesterol.



Researchers have linked mitochondrial mutation to problems with blood
pressure and cholesterol levels

Researchers at Yale and Syracuse universities have found the first direct evidence for a mutation in mitochondrial DNA that affects blood pressure and cholesterol levels.

It has long been known that several metabolic traits including high cholesterol and hypertension cluster in some individuals more frequently than by chance, but the underlying causes were unknown. This study, published in Science Express on line, suggests that altered mitochondria may account for the clustering as well as the disorders.

"Looking further, this finding raises the possibility that all features of the metabolic syndrome may be attributable to altered mitochondrial function," says Richard T. Lifton, the Sterling Professor and chair of genetics at Yale and research team leader.

Metabolic syndrome is an emerging problem in industrial societies and is epidemic in the United States. The symptoms include high blood pressure, cholesterol and triglycerides, insulin resistance, obesity and low HDL (i.e., "good cholesterol"). There is independent evidence that altered mitochondrial function plays a role in insulin resistance and high triglyceride levels, and the current finding indicates that these other components of metabolic syndrome may also be linked to mitochondrial disfunction.

The clear correlation of mutation and disorder in this study was made possible by the evaluation of 142 people in four generations of an affected family. Although family members with each disorder -- hypertension, hypercholesterolemia and hypermagnesemia -- have the same mitochondrial mutation, the presence of the mutation but does not produce all of the symptoms in each individual, report the researchers.

While this study focuses on a rare mutation in mitochondria that provides a clear link to specific disorders, mitochondrial function is known to decline with age in normal people and may be contributing to these common traits in the general population, say the scientists.

Other members of the research team included Frederick H. Wilson, Ali Hariri, Anita Farhi, Hongyu Zhao, Kitt Falk Petersen, Hakan R. Toka, Carlo Nelson-Williams, Michael Kashgarian and Gerald I. Schulman at Yale, and Khalid M. Raja and Steven J. Scheinman at Syracuse University. Grants from the National Institutes of Health, the Howard Hughes Medical Institute and the American Heart Association supported this research.

-- By Janet Rettig Emanuel


T H I SW E E K ' SS T O R I E S

Scientists discover fossil of ancient sea spider species

Center to continue studies on smoking with $9 million grant

Researchers have linked mitochondrial mutation . . .

Yale and presidential politics in 2004

Grant supports F&ES students from underrepresented areas

Study finds that estrogen does not always help memory

Scientists devise a method to measure the age of Martian meteorites

Researchers are studying role of brain in nicotine addiction

Performance at Long Wharf marks launch of O'Neill at Yale project

Beekman Cannon, advocate of musical life at Yale

Divinity School alumni are honored for ministry and service

Yale Books in Brief

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home